UK must reform drug pricing to become life sciences superpower, says GSK boss
Shares jump on higher profits as Emma Walmsley is ‘hopeful’ standoff with NHS can be resolvedGSK’s outgoing chief executive, Emma Walmsley, has said Britain will struggle to be a “life...
By Julia Kollewe · The Guardian World
Shares jump on higher profits as Emma Walmsley is ‘hopeful’ standoff with NHS can be resolved GSK’s outgoing chief executive, Emma Walmsley, has said Britain will struggle to be a “life sciences superpower” unless it overhauls drug pricing. As ministers draw up proposals to increase the amount the NHS spends on new medicines by up to 25% , Walmsley said she was “hopeful and ambitious” that the standoff with the pharma industry can be resolved. Continue reading...